Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma
Open Access
- 23 May 2002
- Vol. 94 (11) , 2874-2881
- https://doi.org/10.1002/cncr.10542
Abstract
BACKGROUND It has been reported that p53 regulates the G2‐M checkpoint transition through cyclin B1, and it has been suggested that p53 plays an important role in the development and progression of various malignancies. The objective of the current study was to clarify the role of the cell cycle regulators, cyclin B1 and p53, in patients with esophageal squamous cell carcinoma (ESCC). METHODS Tissue samples from 71 patients with ESCC were included in the current study. Expression levels of cyclin B1 and p53 in samples of normal squamous epithelium, dysplasia, and tumor cells from patients with ESCC were analyzed by immunohistochemistry. RESULTS Several cells in the basement layer of normal epithelium expressed cyclin B1. The number of cyclin B1 positive cells tended to increase as the degree of dysplasia increased from low grade to high grade. More than 20% of tumor cells were cyclin B1 positive in 38 patients (49.3%). Several clinicopathologic parameters, including macroscopic configuration (P < 0.01), pathologic tumor status (P < 0.05), pathologic lymph node status (P < 0.001), pathologic metastatic status (P < 0.01), tumor stage (P < 0.0001), and invasion of lymphatic vessels (P < 0.05), were correlated with the overexpression of cyclin B1. Elevated expression levels of cyclin B1 also were correlated with a poor prognosis in patients with ESCC in univariate analysis (P < 0.0001) and multivariate analysis (P = 0.0135). In contrast, p53 expression exhibited no significant correlation with the level of cyclin B1 expression and was not associated with prognostic parameters in patients with ESCC. CONCLUSIONS These findings suggest that cyclin B1 is involved in the pathogenesis of carcinoma of the esophagus and that elevated levels of cyclin B1 expression, but not p53 expression, may indicate a poor prognosis for patients with ESCC. Cancer 2002;94:2874–81. © 2002 American Cancer Society. DOI 10.1002/cncr.10542Keywords
This publication has 17 references indexed in Scilit:
- Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.Published by Wiley ,2000
- p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell lineBritish Journal of Cancer, 2000
- No prognostic significance of p53 expression in esophageal squamous cell carcinomaJournal of Surgical Oncology, 1999
- Estimates of the worldwide mortality from 25 cancers in 1990International Journal of Cancer, 1999
- Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45Oncogene, 1999
- GADD45 induction of a G 2 /M cell cycle checkpointProceedings of the National Academy of Sciences, 1999
- p53 regulates a G 2 checkpoint through cyclin B1Proceedings of the National Academy of Sciences, 1999
- Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinomaVirchows Archiv, 1999
- Expression of PCNA andp53 in esophageal dysplasia and esophageal carcinomaSurgery Today, 1997
- Immune Response to Cyclin B1 in Hepatocellular CarcinomaHepatology, 1997